Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tanya Vapnik is active.

Publication


Featured researches published by Tanya Vapnik.


International Clinical Psychopharmacology | 2005

St John's wort versus placebo in obsessive–compulsive disorder: results from a double-blind study

Kenneth A. Kobak; Leslie V. H. Taylor; Alexander Bystritsky; Cary J. Kohlenberg; John H. Greist; Phebe Tucker; Gemma Warner; Rise Futterer; Tanya Vapnik

Although St Johns wort (Hypericum perforatum) is one of the most widely used and studied herbal medicines for depression, less is known about its efficacy in anxiety disorders, in spite of the fact that patients with anxiety disorders are among the most likely to self-medicate using alternative treatments. Pharmacokinetic evidence for the serotonergic, domaminergic and GABAminergic activity of hypericum, and a recent successful open-label study, suggests that it may be effective for obsessive–compulsive disorder (OCD). Sixty subjects were randomized to 12 weeks of treatment with St Johns wort (LI 160) or matching placebo. Subjects with Hamilton Depression Scale scores of 16 or above were excluded. A flexible-dose schedule was utilized (600–1800 mg/day). The mean change on the Yale–Brown Obsessive–Compulsive Scale (Y-BOCS) with St Johns wort (3.43) was not significantly different than the mean change found with placebo (3.60) (P=899). No significant differences were found on any of the Y-BOCS subscales. The percentage of patients rated as ‘much’ or ‘very much’ improved at endpoint was not significantly different between St Johns wort (17.9%) and placebo (16.7%) (P=0.905). Only one patient from each group discontinued due to adverse events [sinus infection (St Johns wort); confusion (placebo)]. The results fail to support the efficacy of St Johns wort for OCD.


Biological Psychiatry | 1995

Ambulatory monitoring of panic patients during regular activity: A preliminary report

Alexander Bystritsky; Michelle G. Craske; Emanuel Maidenberg; Tanya Vapnik; David Shapiro

Ten patients with panic disorder and 10 matched control subjects were compared as to their blood pressure and heart rate during regular daily activity. Physiological responses were monitored by ambulatory recorder, and subjective reports of mood were collected. Data were analyzed controlling for activity and stress level of the subjects. Diastolic blood pressure emerged as a possible discriminatory factor between the groups. A trend for higher heart rate occurred in the panic group. In behavioral terms, panic patients tended to avoid anxiety-provoking situations, resulting in anxiety ratings comparable to those of the control group. Thus, recorded physiological differences between the groups may reflect heightened baseline autonomic activity in panic patients.


The Journal of Clinical Psychiatry | 2002

Obsessive-compulsive hoarding: Symptom severity and response to multimodal treatment.

Sanjaya Saxena; Karron M. Maidment; Tanya Vapnik; Gina Golden; Tanya Rishwain; Richard Rosen; Gerald Tarlow; Alexander Bystritsky


The Journal of Clinical Psychiatry | 2004

Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial.

Alexander Bystritsky; Deborah L. Ackerman; Richard Rosen; Tanya Vapnik; Eda Gorbis; Karron M. Maidment; Sanjaya Saxena


Depression and Anxiety | 2001

Social functioning and quality of life comparisons between obsessive-compulsive and schizophrenic disorders

Alexander Bystritsky; Robert Paul Liberman; Sun Hwang; Charles J. Wallace; Tanya Vapnik; Karron Maindment; Sanjaya Saxena


Journal of Psychiatric Research | 2011

Quality of life and functional impairment in compulsive hoarding

Sanjaya Saxena; Catherine R. Ayers; Karron M. Maidment; Tanya Vapnik; Julie Loebach Wetherell; Alexander Bystritsky


Psychiatric Services | 1999

Quality-of-Life Changes Among Patients With Obsessive-Compulsive Disorder in a Partial Hospitalization Program

Alexander Bystritsky; Sanjaya Saxena; Karron M. Maidment; Tanya Vapnik; Gerald Tarlow; Richard Rosen


The Journal of Clinical Psychiatry | 2001

A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.

Sanjaya Saxena; Arie Winograd; Jennifer J. Dunkin; Karron M. Maidment; Richard Rosen; Tanya Vapnik; Gerald Tarlow; Alexander Bystritsky


The Journal of Clinical Psychiatry | 2005

Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: An open-label study

Ann M. Bogan; Lorrin M. Koran; Helen W. Chuong; Tanya Vapnik; Alexander Bystritsky


Psychopharmacology Bulletin | 2008

A pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorder.

Alexander Bystritsky; Lauren Kerwin; Jamie D. Feusner; Tanya Vapnik

Collaboration


Dive into the Tanya Vapnik's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Richard Rosen

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sanjaya Saxena

University of California

View shared research outputs
Top Co-Authors

Avatar

A.M. Steinberg

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Shapiro

University of California

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge